Iloperidone: A Potential Treatment Option for Bipolar Mania

The Psychopharmacology Institute is an online platform offering unbiased, practical psychopharmacology updates for healthcare providers, with content updated monthly. It also presents opportunities to earn CME and SA credits.
This volume features Dr. Paul Zarkowski, who discusses the results of a study on the use of iloperidone in patients with bipolar disorder. Iloperidone, a medication originally intended for schizophrenia, could also be beneficial for patients with bipolar mania.
The trial was carefully controlled to reduce confounding variables, but does the population studied really represent the diversity seen in a community mental health center?
Find the transcript of this section here: psychopharmacologyinstitute.c...
Did we mention you can also earn CME credits? This is something that you can take advantage of as a Silver or Gold member. Want to know more about Quick Takes and memberships? Click here: psychopharmacologyinstitute.c...
#BipolarManiaTreatment #IloperidoneResearch #MentalHealthAwareness #AdvancementsInPsychiatry